Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Cash from Operations: 2009-2024

Historic Cash from Operations for Rockwell Medical (RMTI) over the last 16 years, with Dec 2024 value amounting to $4.2 million.

  • Rockwell Medical's Cash from Operations fell 131.74% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.1 million, marking a year-over-year decrease of 164.81%. This contributed to the annual value of $4.2 million for FY2024, which is 144.65% up from last year.
  • According to the latest figures from FY2024, Rockwell Medical's Cash from Operations is $4.2 million, which was up 144.65% from -$9.4 million recorded in FY2023.
  • Rockwell Medical's Cash from Operations' 5-year high stood at $4.2 million during FY2024, with a 5-year trough of -$33.5 million in FY2021.
  • Its 3-year average for Cash from Operations is -$7.4 million, with a median of -$9.4 million in 2023.
  • In the last 5 years, Rockwell Medical's Cash from Operations decreased by 13.13% in 2021 and then surged by 144.65% in 2024.
  • Rockwell Medical's Cash from Operations (MRY) stood at -$29.6 million in 2020, then dropped by 13.13% to -$33.5 million in 2021, then skyrocketed by 49.52% to -$16.9 million in 2022, then surged by 44.40% to -$9.4 million in 2023, then surged by 144.65% to $4.2 million in 2024.
  • Its Cash from Operations stands at $4.2 million for FY2024, versus -$9.4 million for FY2023 and -$16.9 million for FY2022.